PLUS•globenewswire•
Plus Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Summary
No near-term Reverse Stock Split required to meet Bid Price Rule No near-term Reverse Stock Split required to meet Bid Price Rule
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 17, 2025 by globenewswire